Sharon Manson's 45-year career in oncology nursing includes roles from bedside nurse to assistant vice president of oncology ...

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a ...

From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, ...

Disorganization, Smith said, is a common theme when it comes to the challenges around coordinating cancer care for a loved ...

Enhertu maintained HRQOL and neurological function in HER2-positive metastatic breast cancer patients, regardless of brain ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, ...

Embrace Gratitude: I must reflect on what I’m thankful for each year. This practice reshaped my perspective on life. Create a ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.